These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10463044)

  • 1. Detecting adverse drug reactions.
    Rosenbloom D; Wynne C
    CMAJ; 1999 Aug; 161(3):247-8. PubMed ID: 10463044
    [No Abstract]   [Full Text] [Related]  

  • 2. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
    Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
    Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.
    van Puijenbroek EP; Bate A; Leufkens HG; Lindquist M; Orre R; Egberts AC
    Pharmacoepidemiol Drug Saf; 2002; 11(1):3-10. PubMed ID: 11998548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacovigilance on the turn? Adverse reactions methods in 2012.
    Herxheimer A
    Int J Risk Saf Med; 2013 Jan; 25(1):29-31. PubMed ID: 23442295
    [No Abstract]   [Full Text] [Related]  

  • 6. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data.
    Sejvar JJ; Kohl KS; Bilynsky R; Blumberg D; Cvetkovich T; Galama J; Gidudu J; Katikaneni L; Khuri-Bulos N; Oleske J; Tapiainen T; Wiznitzer M;
    Vaccine; 2007 Aug; 25(31):5771-92. PubMed ID: 17570566
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse Drug Reaction Project.
    Blustein JN; Miesbauer KM; Saine D; Williams NF; Gold JA
    Wis Med J; 1997 Mar; 96(3):48-9. PubMed ID: 9086860
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Rüggeberg JU; Gold MS; Bayas JM; Blum MD; Bonhoeffer J; Friedlander S; de Souza Brito G; Heininger U; Imoukhuede B; Khamesipour A; Erlewyn-Lajeunesse M; Martin S; Mäkelä M; Nell P; Pool V; Simpson N;
    Vaccine; 2007 Aug; 25(31):5675-84. PubMed ID: 17448577
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of gender on reporting of MMR adverse events in Saudi Arabia.
    Khalil MK; Al-Mazrou YY; Al-Ghamdi YS; Tumsah S; Al-Jeffri M; Meshkhas A
    East Mediterr Health J; 2003; 9(1-2):152-8. PubMed ID: 15562745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Wise RP; Bonhoeffer J; Beeler J; Donato H; Downie P; Matthews D; Pool V; Riise-Bergsaker M; Tapiainen T; Varricchio F;
    Vaccine; 2007 Aug; 25(31):5717-24. PubMed ID: 17493712
    [No Abstract]   [Full Text] [Related]  

  • 12. Systematic identification and classification of adverse events in human research.
    Silverman DI; Cirullo L; DeMartinis NA; Damato K; DeMeo M; Fernandez GA; Glynn L; Hegde U; Laskay E; Leger R; Abu-Hasaballah K; Caron JM
    Contemp Clin Trials; 2006 Jun; 27(3):295-303. PubMed ID: 16624631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data.
    Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; Trolin I; Norton SA; Neff JM;
    Vaccine; 2007 Aug; 25(31):5725-34. PubMed ID: 17532547
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Jones JF; Kohl KS; Ahmadipour N; Bleijenberg G; Buchwald D; Evengard B; Jason LA; Klimas NG; Lloyd A; McCleary K; Oleske JM; White PD;
    Vaccine; 2007 Aug; 25(31):5685-96. PubMed ID: 17400340
    [No Abstract]   [Full Text] [Related]  

  • 15. Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Beigel J; Kohl KS; Brinley F; Graham PL; Khuri-Bulos N; LaRussa PS; Nell P; Norton S; Stoltman G; Tebaa A; Warschaw K;
    Vaccine; 2007 Aug; 25(31):5745-53. PubMed ID: 17537552
    [No Abstract]   [Full Text] [Related]  

  • 16. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data.
    Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I;
    Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data.
    Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Varricchio F; Rothstein E; Schuind A; Hennig R;
    Vaccine; 2007 Aug; 25(31):5858-74. PubMed ID: 17548132
    [No Abstract]   [Full Text] [Related]  

  • 19. Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data.
    Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Hennig R; Rothstein E; Schuind A; Varricchio F;
    Vaccine; 2007 Aug; 25(31):5839-57. PubMed ID: 17553602
    [No Abstract]   [Full Text] [Related]  

  • 20. Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Wenger P; Oleske JM; Kohl KS; Fisher MC; Brien JH; Graham PL; LaRussa PS; Lipton S; Tierney B;
    Vaccine; 2007 Aug; 25(31):5754-62. PubMed ID: 17537553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.